Henry A Fernandez - Net Worth and Insider Trading

Henry A Fernandez Net Worth

The estimated net worth of Henry A Fernandez is at least $1.0 Billion dollars as of 2024-04-27. Henry A Fernandez is the Chairman and CEO of MSCI Inc and owns about 2,103,546 shares of MSCI Inc (MSCI) stock worth over $1.0 Billion. Henry A Fernandez is also the Director of Royalty Pharma PLC and owns about 76,136 shares of Royalty Pharma PLC (RPRX) stock worth over $2 Million. Details can be seen in Henry A Fernandez's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Henry A Fernandez has not made any transactions after 2024-04-25 and currently still holds the listed stock(s).

Transaction Summary of Henry A Fernandez

To

Henry A Fernandez Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Henry A Fernandez owns 2 companies in total, including Royalty Pharma PLC (RPRX) , and MSCI Inc (MSCI) .

Click here to see the complete history of Henry A Fernandez’s form 4 insider trades.

Insider Ownership Summary of Henry A Fernandez

Ticker Comapny Transaction Date Type of Owner
RPRX Royalty Pharma PLC 2022-06-24 director
MSCI MSCI Inc 2019-11-22 director & Chairman & CEO and President

Henry A Fernandez Latest Holdings Summary

Henry A Fernandez currently owns a total of 2 stocks. Among these stocks, Henry A Fernandez owns 2,103,546 shares of MSCI Inc (MSCI) as of April 25, 2024, with a value of $1.0 Billion and a weighting of 99.79%. Henry A Fernandez also owns 76,136 shares of Royalty Pharma PLC (RPRX) as of February 24, 2022, with a value of $2 Million and a weighting of 0.21%.

Latest Holdings of Henry A Fernandez

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MSCI MSCI Inc 2024-04-25 2,103,546 477.78 1,005,032,208
RPRX Royalty Pharma PLC 2022-02-24 76,136 28.00 2,131,808

Holding Weightings of Henry A Fernandez


Henry A Fernandez Form 4 Trading Tracker

According to the SEC Form 4 filings, Henry A Fernandez has made a total of 2 transactions in MSCI Inc (MSCI) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in MSCI Inc is the acquisition of 13,000 shares on April 25, 2024, which cost Henry A Fernandez around $6 Million.

According to the SEC Form 4 filings, Henry A Fernandez has made a total of 2 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Royalty Pharma PLC is the acquisition of 32,500 shares on February 24, 2022, which cost Henry A Fernandez around $1 Million.

Insider Trading History of Henry A Fernandez

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Henry A Fernandez Trading Performance

GuruFocus tracks the stock performance after each of Henry A Fernandez's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry A Fernandez is -12.73%. GuruFocus also compares Henry A Fernandez's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry A Fernandez within 3 months outperforms 3 times out of 15 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Henry A Fernandez's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Henry A Fernandez

Average Return

-4.39%

Average return per transaction

Outperforming Transactions

27%

4 out of 15 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.06 -12.73 -2.96 -4.39 8.33 9.25
Relative Return to S&P 500(%) -3.18 -7.37 4.05 6.16 7.11 3.54

Henry A Fernandez Ownership Network

Ownership Network List of Henry A Fernandez

No Data

Ownership Network Relation of Henry A Fernandez


Henry A Fernandez Owned Company Details

What does Royalty Pharma PLC do?

Who are the key executives at Royalty Pharma PLC?

Henry A Fernandez is the director of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .

Royalty Pharma PLC (RPRX) Insider Trades Summary

Over the past 18 months, Henry A Fernandez made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 420,000 shares made by George W. Lloyd , a net sale of 2,479,950 shares made by Rory B Riggs , and a net purchase of 600,000 shares made by Pablo G. Legorreta .

In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,484,548 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 3,884,548 shares.

Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Royalty Pharma PLC Insider Transactions

No Available Data

Henry A Fernandez Mailing Address

Above is the net worth, insider trading, and ownership report for Henry A Fernandez. You might contact Henry A Fernandez via mailing address: Msci Inc., 88 Pine Street, New York Ny 10005.

Discussions on Henry A Fernandez

No discussions yet.